NVOS OTC
Novo Integrated Sciences, Inc.
1W: -84.6%
1M: +0.0%
3M: -82.9%
YTD: -77.8%
1Y: -88.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
+0.0% ▲
Capital Expenditures
$49K
+0.0% ▲
5Y CAGR: -14.5%
Free Cash Flow
-$2M
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$2M
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$4M | -$33M | -$13M | -$13M |
| Depreciation & Amort. | $1M | $2M | $3M | $2M | $2M |
| Stock-Based Comp. | $2M | $155K | $427K | $385K | $0 |
| Change in Working Capital | -$871K | -$29K | -$823K | $461K | -$1M |
| Other Non-Cash Items | $1M | $2M | $8M | $8M | $10M |
| Operating Cash Flow | -$442K | -$1M | -$6M | -$2M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$12K | -$256K | -$190K | -$49K | -$49K |
| Acquisitions (Net) | -$637K | $4M | $57K | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $1M | -$473K | $296K | $0 | $0 |
| Investing Cash Flow | $657K | $3M | $163K | -$49K | -$49K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$186K | -$3M | -$444K | -$2M | $5M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$199K | -$234K | $17K | $540K | -$4M |
| Financing Cash Flow | -$272K | $4M | -$427K | $764K | $764K |
| Net Change in Cash | -$16K | $6M | -$6M | -$2M | -$2M |
| Cash End of Period | $2M | $8M | $2M | $416K | $416K |
| Free Cash Flow | -$454K | -$1M | -$6M | -$2M | -$2M |